As of 2025-05-16, the EV/EBITDA ratio of Milestone Pharmaceuticals Inc (MIST) is -2.14. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MIST's latest enterprise value is 93.12 mil USD. MIST's TTM EBITDA according to its financial statements is -43.45 mil USD. Dividing these 2 quantities gives us the above MIST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-05-16 | -2.11 |
| 2025-05-15 | -2.06 |
| 2025-05-14 | -2.08 |
| 2025-05-13 | -2.11 |
| 2025-05-12 | -2.12 |
| 2025-05-09 | -2.01 |
| 2025-05-08 | -2.12 |
| 2025-05-07 | -2.23 |
| 2025-05-06 | -2.22 |
| 2025-05-05 | -2.28 |
| 2025-05-02 | -2.25 |
| 2025-05-01 | -2.27 |
| 2025-04-30 | -2.27 |
| 2025-04-29 | -2.16 |
| 2025-04-28 | -2.30 |
| 2025-04-25 | -2.22 |
| 2025-04-24 | -2.19 |
| 2025-04-23 | -2.07 |
| 2025-04-22 | -1.95 |
| 2025-04-21 | -1.89 |
| 2025-04-17 | -1.74 |
| 2025-04-16 | -1.65 |
| 2025-04-15 | -1.67 |
| 2025-04-14 | -1.67 |
| 2025-04-11 | -1.59 |
| 2025-04-10 | -1.57 |
| 2025-04-09 | -1.53 |
| 2025-04-08 | -1.45 |
| 2025-04-07 | -1.48 |
| 2025-04-04 | -1.50 |
| 2025-04-03 | -1.57 |
| 2025-04-02 | -1.63 |
| 2025-04-01 | -1.58 |
| 2025-03-31 | -1.63 |
| 2025-03-28 | -1.73 |
| 2025-03-27 | -3.41 |
| 2025-03-26 | -3.11 |
| 2025-03-25 | -2.95 |
| 2025-03-24 | -3.16 |
| 2025-03-21 | -2.98 |
| 2025-03-20 | -3.04 |
| 2025-03-19 | -3.09 |
| 2025-03-18 | -3.57 |
| 2025-03-17 | -3.60 |
| 2025-03-14 | -3.31 |
| 2025-03-13 | -3.14 |
| 2025-03-12 | -3.01 |
| 2025-03-11 | -2.87 |
| 2025-03-10 | -2.93 |
| 2025-03-07 | -2.90 |